QXO Inc. Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? QXO Inc. Common Stock trades at $10.39 (market cap $10.72B), while UBS Group AG Registered Ordinary Shares trades at $47.69 (market cap $145.08B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 13.5× QXO Inc. Common Stock's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.33% dividend while QXO Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold QXO Inc. Common Stock for 0 Days and UBS Group AG Registered Ordinary Shares for 3 Days on average.
| QXO | UBS | |
|---|---|---|
Market Cap | $10.72B | $145.08B |
Volume | 34,000,619 | 1,613,745 |
Sector | Industrials | Financials |
52-Week High | $27.07 | $55.72 |
52-Week Low | $10.33 | $36.41 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $16.04B | $304.42B |
Dividend Yield | — | 2.33% |
Signals from Pluang's Aura AI — not financial advice
QXO trades at $11.02, up 3.57% on the day but down significantly year-to-date amid weak residential demand and integration challenges from its TopBuild acquisition. The stock shows neutral technical signals with support near $10-$11 and resistance at $12. Fundamentally, revenue grew to $6.84B in 2025 but net losses deepened to $279.4M, with a negative profit margin of -5.17% in 2026. Analyst sentiment remains bullish with a $22.89 consensus target, though recent news highlights margin pressure and execution risks.
The outlook hinges on successful integration of acquisitions and EBITDA growth targets, but high execution risk, negative earnings, and sector headwinds pose substantial downside. With 100% buy ratings from analysts and institutional accumulation, patient investors may see upside if management delivers on its playbook, though volatility is expected near-term.
UBS trades at $47.85, showing minimal daily movement with a 0.06% gain. The technical picture is bearish with mixed earnings performance - beating estimates in Q1 2026 but missing in Q4 2025 and Q2 2026. Analyst sentiment leans positive with 55% buy ratings, though the consensus price target of $23.57 sits well below current levels. Recent news highlights UBS's strategic focus on US expansion and ongoing integration challenges.
The outlook remains cautious given the bearish technical signals and valuation concerns. Investment opportunity exists in the company's improving profitability and revenue growth trajectory, but risks include integration challenges from recent acquisitions and exposure to European debt market volatility. The significant gap between current price and analyst targets warrants careful consideration.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
QXO, Inc. is a distributor of roofing, insulation, waterproofing, and other building materials, serving contractors and builders across US and Canada through its network of branch locations.
Read more on QXO →UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →